ContributorNetwork - In what is being hailed as a hallmark in health care, the U.S. Food and Drug Administration has approved Benlysta, a medication designed for treatment of lupus erythematosus. Not only is Benlysta the first new drug for lupus in more than 50 years to reach the market, but it is the first drug derived from the study of genes (genomics), reports The Wall Street Journal.
You are here:
Health 
Diseases & Conditions First New Lupus Drug in 50 Years Wins FDA Approval
(ContributorNetwork)
Diseases & Conditions First New Lupus Drug in 50 Years Wins FDA Approval
(ContributorNetwork)
